株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医薬品膜ろ過の世界市場 (〜2021年):製品・技術・用途・地域別の動向と予測

Pharmaceutical Membrane Filtration Market by Product (MCE, Coated Cellulose Acetate, Nylon, PVDF Membrane), Technique (Microfiltration, Ultra Filtration, Nanofiltration), Application (Final Product, Raw Material) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 297256
出版日 ページ情報 英文 142 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.29円で換算しております。
Back to Top
医薬品膜ろ過の世界市場 (〜2021年):製品・技術・用途・地域別の動向と予測 Pharmaceutical Membrane Filtration Market by Product (MCE, Coated Cellulose Acetate, Nylon, PVDF Membrane), Technique (Microfiltration, Ultra Filtration, Nanofiltration), Application (Final Product, Raw Material) - Global Forecast to 2021
出版日: 2017年01月25日 ページ情報: 英文 142 Pages
概要

2016年における世界の医薬品膜ろ過市場は、35億5,000万米ドルの規模であり、今後CAGR(複合年間成長率)11.8%の伸びで拡大し、2021年には62億米ドルの規模に達する見込みとなっています。同市場の成長により、ナノ濾過技術の採用、バイオ医薬品産業の成長およびジェネリック医薬品の急速な発展に繋がっています。しかしその一方で、厳格な規制要件と高額さによる制約が市場成長を抑制しています。

当レポートでは、世界の医薬品膜ろ過市場を取り上げ、技術別・用途別・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルなどをまとめた結果をお届けいたします。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 市場発展促進因子
    • 市場発展阻害要因
    • 市場機会
    • 課題
    • 動向

第6章 医薬品膜ろ過市場:製品別

  • イントロダクション
  • MCE膜ろ過
  • 被覆酢酸セルロース
  • ナイロン
  • PTFE膜
  • PVDF膜
  • その他の膜ろ過

第7章 医薬品膜ろ過市場:技術別

  • イントロダクション
  • 精密ろ過
  • 限外ろ過
  • ナノろ過
  • 逆浸透
  • イオン交換

第8章 医薬品膜ろ過市場、用途別

  • イントロダクション
  • 最終製品の加工
  • 原材料のろ過
  • 空気清浄
  • 細胞分離
  • 浄水

第9章 医薬品膜ろ過市場、地域別

  • イントロダクション
  • 北米(米国、カナダ)
  • 欧州
  • アジア
  • ROW(その他地域)

第10章 競合環境

  • イントロダクション
  • 戦略分析
  • 市場シェア分析
  • 競合状況および動向
    • 新製品発表
    • 合併・買収
    • 合意および協業
    • 事業拡張
    • その他の動き

第11章 企業プロファイル(概要、製品・サービス、財務、戦略・発展動向など)

  • イントロダクション
  • Merck KGaA
  • General Electric Company
  • Danaher Corporation (Pall Corporation)
  • Sartorius Stedim Biotech S.A.
  • 3M Company
  • ALFA Laval
  • Graver Technologies, LLC
  • Koch Membrane System
  • GEA Group
  • Novasep

第12章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2255

The global pharmaceutical membrane filtration market is expected to reach USD 6.20 billion by 2021 from USD 3.55 billion in 2016, at a CAGR of 11.8% from 2016 to 2021. Growth in the biopharmaceutical industry and advancements in the nanofiltration technology are the key factors driving the growth of the market. On the other hand, strict government regulations for validation of the filtration process and low adoption of membrane filters in emerging markets due to cost constraints are the major factors restraining the growth of this market.

Factors such as increase in the growth of biopharmaceutical industry and rapid growth in generic drug production are driving the global pharmaceutical Filtration market. However stringent government regulations for validation of the filtration process hindering the growth of this market.

The global pharmaceutical membrane filtration market has been segmented on the basis of type of products, technique, application, and region.

On the basis of product, the pharmaceutical membrane filtration market is segmented into MCE membrane filters, coated cellulose acetate membrane filters, nylon membrane filters, PTFE membrane filters, PVDF membrane filters, and other membrane filters. The MCE membrane filters segment is expected to account for the largest and fastest-growing segment of the global pharmaceutical membrane filtration market in 2016. The large share of this segment is primarily attributed to the increasing adoption of different types of membrane filters for various filtration applications and the frequent use of these filters as compared to prefilters, single-use systems, and cartridges & capsules. The increasing focus of the pharmaceutical industries can also lead to the adoption rate of biopharmaceutical industry has resulted in the increase in demand for pharmaceutical membrane Filtration products.

Based on product, the pharmaceutical membrane filtration market is segmented into MCE, coated cellulose, nylon, PTFE membrane, PVDF membrane, other membrane. The MCE membrane product is estimated to witness the highest CAGR during the forecast period, 2016 to 2021. Due to high production of pharmaceutical products and drugs, MCE attributes the largest share.

Based on technique, the pharmaceutical membrane filtration market has beenis segmented into microfiltration, nano filtration, crossfiltration, ultrafiltration, reverse osmosis, and ion exchange. The microfiltration segment is anticipated expected to grow at the highest CAGR during the forecast period.from 2016 to 2021. The high adoption of microfiltration over other techniques in pharmaceutical applications accounts for the large share of this segment. The high growth in this segment is due to the rising demand the research and medical services.

On the basisBased on application, the global pharmaceutical membrane filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification, Processing, Raw material filtration. The final product processing segment is further classified into active pharmaceutical ingredient filtration, sterile filtration, protein purification, vaccine and & antibody processing, formulation and & filling solutions, and viral clearance. Among the applications, The final product processing segment is expected to witness the highest growth rate during the forecast period, due to advancement of Nano-filtration.

Geographically, the market is segmented into four regions, namely, North America, Europe, Asia, and RoW. and rest of the world (ROW). The global pharmaceutical membrane filtration market is dominated by North America, followed by Europe. The growth of this market is mainly driven by the growth in the pharmaceutical industry, increasing incidence of airborne disease, rapid expansion of generics production, and advancements in nanofiber technology.

Growth in the North American region is due to the increasing in incidence of airborne diseases which will boost the growth of this market. Also, R&D growth and spending on pharmaceutical and biotechnology projects and the rising number of drug development projects are important drivers for the pharmaceutical filtration market in North America. Besides this, the large size of the North American biotechnology industry is expected to continue to drive the growth of the pharmaceutical filtration market in this region.

The major players in the global pharmaceutical membrane filtration market include Merck KGaA (Germany), GE Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), and GEA Group (Germany).Merck KGaA (Germany), General Electric Company (U.S.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), ALFA LAVAL (Sweden), Graver Technologies, LLC (U.S.), Koch membrane system (U.S.), and GEA Group (Germany).

Research Coverage:

This report aims to provide insights on the global pharmaceutical membrane filtration market. It provides valuable information on the type of product, technique, application, and regionsnal segments of the global pharmaceutical filtration market. The report also covers the market dynamics which includes the drivers, restraints, opportunities and challenges of the global pharmaceutical membrane filtration market. This report covers the competitive landscape of the top ten companies in the global pharmaceutical membrane filtration market. The competitive landscape includes a comparison between the companies and the strategies adopted by them in order to continue their presence in the Pharmaceutical membrane filtration market.

Value Addition for the Buyer:

The above mentioned information would benefit buyers by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years.

In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output, in order to remain successful in the global pharmaceutical membrane filtration market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKET COVERED
    • 1.3.2. YEARS CONSIDERED IN THE REPORT
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL PHARMACEUTICAL MEMBRANE FILTRATION MARKET OVERVIEW

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Growth in the biopharmaceutical industry
      • 5.2.1.2. Advancements in the nanofiltration technology
      • 5.2.1.3. Growing application in the control of airborne diseases
      • 5.2.1.4. Significant rise in generic drug production
      • 5.2.1.5. Strong biologics pipeline
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. Strict government regulations for validation of the filtration process
      • 5.2.2.2. Low adoption of membrane filters in emerging markets due to cost constraints
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. Growth potential in emerging markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Intense competition in the market is a critical entry barrier for new entrants
    • 5.2.5. TRENDS
      • 5.2.5.1. Rising adoption of single-use technologies

6. PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. MCE MEMBRANE FILTERS
  • 6.3. COATED CELLULOSE ACETATE
  • 6.4. NYLON
  • 6.5. PTFE MEMBRANE
  • 6.6. PVDF MEMBRANE
  • 6.7. OTHER MEMBRANE FILTERS

7. PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE

  • 7.1. INTRODUCTION
  • 7.2. MICROFILTRATION
  • 7.3. ULTRAFILTRATION
  • 7.4. NANOFILTRATION
  • 7.5. REVERSE OSMOSIS
  • 7.6. ION EXCHANGE

8. PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. FINAL PRODUCT PROCESSING
  • 8.3. RAW MATERIAL FILTRATION
  • 8.4. AIR PURIFICATION
  • 8.5. CELL SEPARATION
  • 8.6. WATER PURIFICATION

9. PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
  • 9.4. ASIA
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. STRATEGIC ANALYSIS
  • 10.3. MARKET SHARE ANALYSIS
  • 10.4. COMPETITIVE SITUATION AND TRENDS
    • 10.4.1. PRODUCT LAUNCHES AND UPGRADES
    • 10.4.2. MERGERS & ACQUISITIONS
    • 10.4.3. AGREEMENTS AND COLLABORATIONS
    • 10.4.4. EXPANSIONS
    • 10.4.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 11.1. INTRODUCTION
  • 11.2. MERCK KGAA
  • 11.3. GENERAL ELECTRIC COMPANY
  • 11.4. DANAHER CORPORATION (PALL CORPORATION)
  • 11.5. SARTORIUS STEDIM BIOTECH S.A.
  • 11.6. 3M COMPANY
  • 11.7. ALFA LAVAL
  • 11.8. GRAVER TECHNOLOGIES, LLC
  • 11.9. KOCH MEMBRANE SYSTEM
  • 11.10. GEA GROUP
  • 11.11. NOVASEP

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SUMMARY
  • TABLE 2: GROWTH IN THE BIOPHARMACEUTICAL INDUSTRY IS PROPELLING THE GROWTH OF THE PHARMACEUTICAL MEMBRANE FILTRATION MARKET
  • TABLE 3: STRINGENT GOVERNMENT REGULATIONS FOR VALIDATION OF THE FILTRATION PROCESS ARE EXPECTED TO RESTRICT MARKET GROWTH
  • TABLE 4: RISING OPPORTUNITIES IN THE EMERGING MARKETS TO BOOST THE GROWTH OF THE PHARMACEUTICAL MEMBRANE FILTRATION MARKET
  • TABLE 5: INTENSE COMPETITION ACTS AS AN ENTRY BARRIER FOR NEW ENTRANTS
  • TABLE 6: RISING ADOPTION OF SINGLE-USE TECHNOLOGIES IS A MAJOR TREND FOR MARKET PLAYERS
  • TABLE 7: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 8: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR MCE (NITROCELLULOSE), BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR COATED CELLULOSE ACETATE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR NYLON BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR PTFE MEMBRANE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR PVDF MEMBRANE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR OTHER MEMBRANE FILTERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 15: PHARMACEUTICAL MICROFILTRATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: PHARMACEUTICAL ULTRAFILTRATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: PHARMACEUTICAL NANOFILTRATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: PHARMACEUTICAL REVERSE OSMOSIS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: PHARMACEUTICAL ION EXCHANGE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 21: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR FINAL PRODUCT PROCESSING, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 22: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR FINAL PRODUCT PROCESSING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR RAW MATERIAL FILTRATION, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 24: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR RAW MATERIAL FILTRATION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR AIR PURIFICATION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR CELL SEPARATION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR WATER PURIFICATION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 31: NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 32: NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: FINAL PRODUCT PROCESSING MARKET SIZE, BY SUBSEGMENTS, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: RAW MATERIAL APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 35: U.S.: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 36: U.S.: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 37: U.S.: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 38: U.S. FINAL PRODUCT PROCESSING MARKET SIZE, BY SUBSEGMENTS, 2014-2021 (USD MILLION)
  • TABLE 39: U.S.: RAW MATERIAL APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 40: CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 41: CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 42: CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 43: CANADA. FINAL PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 44: CANADA: RAW MATERIAL APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 46: EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: FINAL PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE: RAW MATERIAL APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 50: ASIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 51: ASIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 52: ASIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 53: ASIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY FINAL PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 54: ASIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY RAW MATERIAL APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 55: ROW: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 56: ROW: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • TABLE 57: ROW: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 58: ROW : PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY FINAL PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 59: ROW: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY RAW MATERIAL APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 60: MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND JUNE 2016
  • TABLE 61: PRODUCT LAUNCHES AND UPGRADES, 2013-2016
  • TABLE 62: MERGERS & ACQUISITIONS, 2013-2016
  • TABLE 63: AGREEMENTS AND COLLABORATIONS, 2013-2016
  • TABLE 64: EXPANSIONS, 2013-2016
  • TABLE 65: OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: PHARMACEUTICAL MEMBRANE FILTRATION MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY TECHNIQUE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE, BY REGION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: RAPID GROWTH IN GENERICS PRODUCTION TO DRIVE MARKET GROWTH FOR PHARMACEUTICAL MEMBRANE FILTRATION
  • FIGURE 12: ASIA TO FORM THE FASTEST-GROWING REGIONAL SEGMENT IN THE FORECAST PERIOD
  • FIGURE 13: GROWTH IN THE BIOPHARMACEUTICAL INDUSTRY WILL DRIVE THE PHARMACEUTICAL MEMBRANE FILTRATION MARKET
  • FIGURE 14: NUMBER OF BIOTECHNOLOGY PATENTS FILED IN 2014, BY COUNTRY
  • FIGURE 15: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT
  • FIGURE 16: MCE (NITROCELLULOSE) SEGMENT TO COMMAND THE LARGEST SHARE OF THE PHARMACEUTICAL MEMBRANE FILTRATION MARKET IN 2016
  • FIGURE 17: MARKET SEGMENTATION, BY TECHNIQUE
  • FIGURE 18: MICROFILTRATION TO HOLD LARGEST MARKET SHARE DURING THE FORECAST PERIOD
  • FIGURE 19: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 20: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR FINAL PRODUCT PROCESSING, BY TYPE, 2014-2021 (USD MILLION)
  • FIGURE 21: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE FOR RAW MATERIAL FILTRATION, BY TYPE, 2014-2021 (USD MILLION)
  • FIGURE 22: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2016-2021
  • FIGURE 23: PHARMACEUTICAL MEMBRANE FILTRATION MARKET IN ASIA EXPECTED TO GROW AT THE HIGHEST RATE (2016 TO 2021)
  • FIGURE 24: NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SNAPSHOT
  • FIGURE 25: CANADA, THE FASTEST-GROWING REGIONAL SEGMENT IN NORTH AMERICA
  • FIGURE 26: ASIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SNAPSHOT
  • FIGURE 27: KEY DEVELOPMENTS IN THE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2013-2016
  • FIGURE 28: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 29: COMPANY SNAPSHOT: MERCK KGAA
  • FIGURE 30: COMPANY SNAPSHOT: GENERAL ELECTRIC COMPANY
  • FIGURE 31: COMPANY SNAPSHOT: DANAHER CORPORATION
  • FIGURE 32: COMPANY SNAPSHOT: SARTORIUS STEDIM BIOTECH S.A.
  • FIGURE 33: COMPANY SNAPSHOT: 3M COMPANY
  • FIGURE 34: COMPANY SNAPSHOT: ALFA LAVAL
  • FIGURE 35: COMPANY SNAPSHOT: GEA GROUP
Back to Top